Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.
about
The NIH-NIAID Schistosomiasis Resource Center at the Biomedical Research Institute: Molecular ReduxAnalysis of DNA Methylation Status in Bodily Fluids for Early Detection of CancerDNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.Alterations in DNA methylation may be the key to early detection and treatment of schistosomal bladder cancer.The role of aberrant promoter hypermethylation of DACT1 in bladder urothelial carcinoma.Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancerQuantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer.Hypermethylation in bladder cancer: biological pathways and translational applications.Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential.Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application.Epigenetic-dependent regulation of drug transport and metabolism: an update.The bifacial role of helminths in cancer: involvement of immune and non-immune mechanisms.Urine biomarkers of schistosomiais and its associated bladder cancer.Non-blood circulating tumor DNA detection in cancer.Evaluation of urinary HURP mRNA as a marker for detection of bladder cancer: relation to bilharziasis.Lidocaine enhances the effects of chemotherapeutic drugs against bladder cancer.DNA methylation in urothelial carcinoma.Aberrant methylation of APC and RARβ2 genes in breast cancer patients.Aberrant promoter methylation of the RASSF1A and APC genes in epithelial ovarian carcinoma development.MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer.
P2860
Q28079535-84A92D4D-E51F-43A6-BDE7-25D3859F24D4Q33624423-DA975E9D-96AA-46C9-9A5C-80423654929CQ34249360-8DCE961F-1C79-4CB8-AF5A-5D4F8F8F12A1Q35652549-BFE2E86C-B28A-44D2-B467-9C7855847F99Q36732893-377ADBD3-717D-42D9-826F-8530EA12A22DQ36772110-CC7474A8-8A0A-4BFC-9330-D4145F1D304CQ37720392-510E6344-CEF4-4FBD-96B9-1D00F022B062Q37978544-0A1A7424-F939-41FF-94AC-A82F38629320Q38020241-F3083FD6-B149-41F4-BB4A-E1909E70350BQ38038406-1159A61D-57C2-42C7-BE2C-BB181B7813F2Q38042440-0B123ABB-A8F9-4E9F-9228-D8A77BD240BDQ38192723-C568D09D-202B-4AC6-A773-1FB4EEE765AEQ38536270-BDEC6470-A15D-4043-9CE7-032C9A8A0FFFQ42253044-2D2720D0-DA6D-49B3-B4CD-6FE1A45EAD24Q44602037-9EFF442D-728C-426A-B2E1-CAA2D2DAEC5DQ49300793-F1446AC5-0BB9-4FB9-8055-88EC4C8616EAQ53691833-19B90F3F-C934-46AE-8808-89D829200B0FQ53809194-6FADBBF9-E422-4969-97F3-C145CBDA104DQ54288190-83EB457F-5CCD-4268-ABA8-69D334339043Q55425955-D60530F4-9E0D-4C99-9329-3293AFDF8986
P2860
Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Aberrant methylation of RARbet ...... nonbilharzial bladder cancer.
@en
Aberrant methylation of RARbet ...... nonbilharzial bladder cancer.
@nl
type
label
Aberrant methylation of RARbet ...... nonbilharzial bladder cancer.
@en
Aberrant methylation of RARbet ...... nonbilharzial bladder cancer.
@nl
prefLabel
Aberrant methylation of RARbet ...... nonbilharzial bladder cancer.
@en
Aberrant methylation of RARbet ...... nonbilharzial bladder cancer.
@nl
P2093
P50
P1476
Aberrant methylation of RARbet ...... d nonbilharzial bladder cancer
@en
P2093
Ahmed Ibrahim Nossier
Hanan Shehata
Inas M El-Khouly
Menha Swellam
Mohamed A Hamdy
Mohamed Esmat
Nahla M Awad
Omar El-Ahmady
P304
P356
10.1158/1055-9965.EPI-11-0237
P577
2011-06-15T00:00:00Z